Cassava Sciences Inc (NASDAQ:SAVA)
| 49.99 BATS BZX Real-Time Price As of 1:52pm ET |  -2.76 / -5.23%Today’s Change | 6.70 Today|||52-Week Range 146.16 | +632.99% Year-to-Date |
Latest SAVA News | Press Releases
| Cassava Sciences, Inc. (SAVA) Stock Moves -0.52%: What You Should Know Sep 20 / Zacks.com - Paid Partner Content | Do Options Traders Know Something About Cassava Sciences (SAVA) Stock We Don't? Sep 10 / Zacks.com - Paid Partner Content |
| Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know Sep 16 / Zacks.com - Paid Partner Content | Biogen (BIIB) Alzheimer's Drug Aduhelm Sees Slow Launch, Stock Down Sep 10 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 52.75 |
| Today’s open | 51.03 |
| Day’s range | 49.60 - 52.53 |
| Volume | 568,415 |
| Average volume (3 months) | 5,861,710 |
| Market cap | $1.9B |
Data as of 1:52pm ET, 09/22/2021
Growth & Valuation
| Earnings growth (last year) | +8.80% |
| Earnings growth (this year) | -145.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 18.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALECAlector Inc | -0.80 | -3.06% |
| RCKTRocket Pharmaceutica... | -0.17 | -0.52% |
| MYOVMyovant Sciences Ltd | -0.08 | -0.36% |
| ---- |
Data as of 1:52pm ET, 09/22/2021
Financials
| Next reporting date | November 2, 2021 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
